CoronaryAtlas logo
CoronaryAtlas
Inducible Nitric Oxide Synthase
Pathway / Plaque inflammation

Inducible Nitric Oxide Synthase

NOS2gene

iNOS-driven nitric oxide production in macrophages sustains plaque inflammation and impairs endothelial function.

Pathway placement
Cascade stepPlaque inflammation
Confidencemedium
RationaleM1 macrophage marker in atherosclerotic inflammation; endothelial dysfunction in MI.
Also acts inEndothelial activation/erosion
Druggability
DruggableYes
Known drugs / candidates4
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000007171

Type I vs non-Type I discrimination

ScoresNon-Type-I-associated
R — rupture / Type-I
C — non-Type-I
60
A — assay feasibility
52
E — evidence strength
35
T1DI (composite)
5
Specificity differential (R−C)-45
Non-Type-I axis panel
Does this marker also move in each non-Type-I setting? mag 0–3; higher means less Type-I-specific. n/a = no evidence retrieved, which is not the same as no change.
2sepsis / systemic inflammationn/a
2anemia / acute blood lossn/a
2hypovolemia / dehydrationn/a
2tachyarrhythmian/a
2hypoxemia / respiratory failuren/a
2hypertensive emergencymag 2
2high-demand / peri-operative stressn/a
3sudden cardiac deathmag 2
4aPCI-related periproceduralmag 1
4bstent thrombosisn/a
4cin-stent restenosismag 2
5CABG-relatedmag 2
Coverage: 5/12 axes with evidence
Tier: deep-scored (abstract-extracted) · 10 supporting references. See the discrimination table for all markers.

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood — gene is not a circulating analyte; measure protein product or genotype
Collection tube
K2-EDTA whole blood (lavender-top)
Method / principle
SNP genotyping / sequencing; or immunoassay of encoded protein
Reagent / substrate
Allele-specific primers/probes (TaqMan) or NGS panel; or antibody for protein
Platform
qPCR / NGS / array
Turnaround · availability
Send-out · Genotyping widely available; protein assay variable

Human genetic evidence

0.264
Open Targets association (acute_MI)

Literature evidence(4)